Skip to main content
Year archive

RENALYTIX PLC — 2022 filings

All 47 regulatory filings released by RENALYTIX PLC (RENX) in 2022, sourced directly from the official regulator.

47 Filings
2022 Period
2022 filings (47)
Filing Released Lang
Result of AGM
AGM Information
2022-12-19 English
Clinical utility study data: further highlights
Regulatory Filings
2022-12-01 English
Results for First Quarter of Fiscal Year 2023
Earnings Release Q1 2023
2022-11-30 English
Publication of new real world evidence
Environmental & Social Information
2022-11-29 English
Notice of Q1 FY23 Results
Report Publication Announcement
2022-11-22 English
Publication of Annual Report 2022 & Notice of AGM
Report Publication Announcement
2022-11-10 English
Price Monitoring Extension
Regulatory Filings
2022-11-09 English
RENX to Present at Stifel Healthcare Conference
Report Publication Announcement
2022-11-03 English
Second Price Monitoring Extn
Regulatory Filings
2022-10-31 English
Price Monitoring Extension
Regulatory Filings
2022-10-31 English
Renalytix Reports Full Year Fiscal 2022 Results
Earnings Release FY 2022
2022-10-31 English
Second Price Monitoring Extn
Regulatory Filings
2022-10-26 English
Price Monitoring Extension
Regulatory Filings
2022-10-26 English
KidneyIntelX Medicare Update
Regulatory Filings
2022-10-25 English
Notice of Results
Report Publication Announcement
2022-10-24 English
Presentations accepted at ASN Kidney Week
Regulatory Filings
2022-10-17 English
Directorate Change
Board/Management Information
2022-09-20 English
Issue of shares
Declaration of Voting Results & Voting Rights Announcements
2022-09-12 English
Renalytix to Present at H.C. Wainwright Conference
Report Publication Announcement
2022-09-08 English
Business update
Regulatory Filings
2022-08-17 English
Publication of clinical utility study in The AJMC
Regulatory Filings
2022-08-08 English
Renalytix Reports Financial Results for Q3 of FY22
Earnings Release Q3 2022
2022-06-30 English
Renalytix to Report Financial Results for Q3
Report Publication Announcement
2022-06-23 English
Mount Sinai clinical utility data
Regulatory Filings
2022-06-10 English
Renalytix to Present at Growth Stock Conference
Regulatory Filings
2022-06-08 English
Data Presentations at ADA 82nd Scientific Sessions
Environmental & Social Information
2022-06-06 English
KidneyIntelX data shows ability to assess risk
Environmental & Social Information
2022-06-06 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2022-04-29 English
Grant of Share Options
Remuneration Information
2022-04-22 English
Successful completion of $30.0m financing package
Director's Dealing
2022-04-08 English
Issue of shares
Declaration of Voting Results & Voting Rights Announcements
2022-04-08 English
$30.0 million financing package
Capital/Financing Update
2022-03-31 English
Half-year Report
Interim / Quarterly Report H1 2022
2022-03-31 English
Timothy Scannell appointed to the Board
Board/Management Information
2022-03-30 English
Enrollment Milestone for KidneyIntelX
Regulatory Filings
2022-03-29 English
Notice of Results
Report Publication Announcement
2022-03-25 English
Renalytix Launches myIntelX
Earnings Release Q1 2022
2022-03-09 English
Presentation of new clinical data for KidneyIntelX
Regulatory Filings
2022-02-24 English
RENX to Present at Cowen 42nd Annual Conference
Regulatory Filings
2022-02-22 English
Timothy Scannell to be appointed to board
Board/Management Information
2022-02-22 English
Grant of Share Options
Remuneration Information
2022-01-27 English
Conference attendance
Regulatory Filings
2022-01-27 English
Positive Study Results Published for KidneyIntelX
Regulatory Filings
2022-01-11 English
Partnership with Singing River for KidneyIntelX
Regulatory Filings
2022-01-10 English
Appointment of Jean M. Casner as CHRO
Board/Management Information
2022-01-07 English
RENX to present at 40th JP Morgan Healthcare Conf.
Regulatory Filings
2022-01-05 English
Joint program with American Diabetes Association
Environmental & Social Information
2022-01-04 English